Nanocrystalline Silver Technology
Nucryst Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology.
Nucryst has a successful nanocrystalline silver coating business and is developing a pipeline of potential products to target diseases involving infection and/or inflammation.

12/22/09   NUCRYST Announces the Completion of the Sale of its Acticoat Business MORE

11/20/09    NUCRYST Announces Special Meeting of Shareholders MORE

8/5/09 NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 Second Quarter Results   MORE >
5/6/09 NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results   MORE >

To be notified by email of upcoming events and press releases MORE >
© Copyright 2004 NUCRYST Pharmaceuticals Corp. All rights reserved. legal
SILCRYST™ is a trademark of NUCRYST Pharmaceuticals Corp. and Acticoat™ is trademark of Smith & Nephew plc